Clinical Trial

Comparative Outcomes of Radiofrequency Ablation of Concealed and Manifest Accessory Pathways: a Single Center, Retrospective Observational Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this observational, retrospective study is to evaluate, comparatively, procedural outcomes of APs (Accessory pathway) ablation according to the conduction properties (i.e., manifest vs. concealed) and to assess both short- and long-term outcomes of RFA (RF ablation).
Trial Details
NCT Number NCT07435181
Lead Sponsor IRCCS Ospedale San Raffaele
Conditions Atrioventricular Reentrant Tachycardias, Wolff-Parkinson-White (WPW) Syndrome
Enrollment 220 participants
Start Date 2026-04
Primary Completion 2027-04 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-02-27